James Investment Research, Inc. has filed a Form 13F-HR disclosing its equity holdings as of the close of business on September 30, 2026. The filing details a portfolio consisting of 373 individual securities.
The portfolio includes a mix of large-cap technology and healthcare names, as well as various exchange-traded funds (ETFs). Notable positions include Apple Inc., with 106,860 shares; Broadcom Inc., with 38,738 shares; and Eli Lilly & Co., with 10,550 shares. The filing also lists significant holdings in Berkshire Hathaway Inc. Class B, with 10,642 shares, and Goldman Sachs Group Inc., with 13,730 shares.
A substantial portion of the portfolio is allocated to ETFs, including the Invesco S&P 500 Equal Weight ETF, the iShares Core S&P Small-Cap ETF, and the iShares MSCI EAFE ETF. The filing also includes positions in energy companies such as Chevron Corporation and ExxonMobil Holdings Corp.
The report was signed by Lesley Ott, the Chief Compliance Officer of James Investment Research, Inc.
